Billy Delgado, is a
Case Manager/care Coordinator based in Gilroy, California. Billy Delgado is licensed to practice in California (license number ) and his current practice location is
290 Ioof Ave, Gilroy, California. He can be reached at his office (for appointments etc.) via phone at
(408) 846-2100.
NPI number for Billy Delgado is 1528425592 and his current mailing address is 290 Ioof Ave, Gilroy, California. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1528425592.
Healthcare Provider's Profile
| Full Name | Billy Delgado |
|---|
| Gender | Male |
|---|
| Speciality | Case Manager/care Coordinator |
|---|
| Location | 290 Ioof Ave, Gilroy, California |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
|---|
NPI Data:
- NPI Number: 1528425592
- Provider Enumeration Date: 01/21/2016
- Last Update Date: 01/11/2022
Medical Identifiers
Medical identifiers for Billy Delgado such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
|---|
| 1528425592 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Secondary |
| 171M00000X | Case Manager/care Coordinator | (California) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Billy Delgado is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
|---|
Billy Delgado,
290 Ioof Ave,
Gilroy, CA 95020-5204
Ph: (408) 846-2100 | Billy Delgado,
290 Ioof Ave,
Gilroy, CA 95020-5204
Ph: (408) 846-2100 |
Reviews and Comments